Cellbricks GmbH

cachedupdated

appsKey Factsinsert_link

This company profile is a search result of implisense.com

  • Address
    Gustav-Meyer-Allee 25, 13355 Berlin

Register your Implisense account for free

Register quickly and easily for a free Implisense account. Registered users have access to advanced analyses and more key figures on company profiles, receive more extensive search results and can also create and manage their own favorites.

  • content_copy
    Richer Company Profiles
  • search
    Expanded Search Results
  • star_border
    Personal Favourites and Notes

linear_scaleTimelineinsert_link

Funding
Abschluss des Förderprojektes "KMU-innovativ-21: Bio-Production-Line - Aufbau eines biologischen Fließband-3D-Drucks von definierten Gewebekonstrukten für biomedizinische und pharmakologische Studien" (BMBF 031B0648A)

Heute endet das Förderprojekt "KMU-innovativ-21: Bio-Production-Line - Aufbau eines biologischen Fließband-3D-Drucks von definierten Gewebekonstrukten für biomedizinische und pharmakologische Studien". Es wurde vom BMBF unter dem Förderkennzeichen 031B0648A für die Cellbricks GmbH mit einer Summe von 289940 Euro gefördert. Die Laufzeit des Projektes betrug 30 Monate.

Förderkatalog der Bundesregierung
Funding
Beginn des Förderprojektes "Verbundprojekt: Optimierung und Weiterentwicklung eines auf Photopolymerisation basierenden biologischen 3D- Druckverfahrens (Bioprinting) für die personalisierte Akutversorgung in der Schwerelosigkeit, Teilprojekt: Cellbricks GmbH" (BMWi 50WB2035)

Heute startet das Förderprojekt "Verbundprojekt: Optimierung und Weiterentwicklung eines auf Photopolymerisation basierenden biologischen 3D- Druckverfahrens (Bioprinting) für die personalisierte Akutversorgung in der Schwerelosigkeit, Teilprojekt: Cellbricks GmbH". Es wird vom BMWi unter dem Förderkennzeichen 50WB2035 für die Cellbricks GmbH mit einer Summe von 119520 Euro gefördert. Die Laufzeit des Projektes beträgt 24 Monate.

Förderkatalog der Bundesregierung
Funding
Abschluss des Förderprojektes "IBÖM04: XenoGlue - Ein neuartiger Muschel-basierter fotoaktivierbarer Bioklebstoff für biomedizinische Anwendungen" (BMBF 031B0584F)

Heute endet das Förderprojekt "IBÖM04: XenoGlue - Ein neuartiger Muschel-basierter fotoaktivierbarer Bioklebstoff für biomedizinische Anwendungen". Es wurde vom BMBF unter dem Förderkennzeichen 031B0584F für die Cellbricks GmbH mit einer Summe von 160305 Euro gefördert. Die Laufzeit des Projektes betrug 27 Monate.

Förderkatalog der Bundesregierung
Register Filings
Veränderung im Handelsregister

Stamm- bzw. Grundkapital: 30.357,00 EUR;

Registergerichte der Länder der Bundesrepublik Deutschland
Register Filings
Veränderung im Handelsregister

Rechtsform: Durch Beschluss der Gesellschafterversammlung vom 27.08.2019 ist das Stammkapital um 5.357,00 EUR auf 30.357,00 EUR erhöht und der Gesellschaftsvertrag insgesamt neu gefasst.

Registergerichte der Länder der Bundesrepublik Deutschland

assessmentProducts & Servicesinsert_link

Software
Drucker
Forschung
Anwendungen
Additive
Produktion
Prototypen
Projekte
Gewebe
See all 20 entries

Register for a free Implisense account to get advanced analysis and more extensive search results.

account_circleImplisense Account

Cellbricks GmbH is mentioned in public sources in the context of the following products and services. Software, Drucker and Forschung are the most common. The ranking list shown is without guarantee of completeness or correctness.

spaValue Profileinsert_link

Dominance, Competence, ClarityInnovation, Passion, CreativityHarmony, Reliability, CommunicatibilityDilligence, Introspection, Thoroughness
Dominance, Competence, Clarity
Innovation, Passion, Creativity
Harmony, Reliability, Communicatibility
Dilligence, Introspection, Thoroughness

The 4 Color Scheme separates people and their personalities into four groups. Cellbricks GmbH emphasizes the following character types in their external communications and job advertisements.

You can find more information on the FAQ page.

location_onInternational Affairsinsert_link

AfghanistanAngolaAlbaniaUnited Arab EmiratesArgentinaArmeniaAustraliaAustriaAzerbaijanBurundiBelgiumBeninBurkina FasoBangladeshBulgariaBosnia and HerzegovinaBelarusBelizeBoliviaBrazilBrunei DarussalamBhutanBotswanaCentral African RepublicCanada: 3SwitzerlandChileChinaCôte d'IvoireCameroonDemocratic Republic of the CongoCongoColombiaCosta RicaCubaCzechiaGermanyDjiboutiDenmarkDominican RepublicAlgeriaEcuadorEgyptEritreaEstoniaEthiopiaFinlandFijiGabonUnited Kingdom of Great Britain and Northern IrelandGeorgiaGhanaGuineaGambiaGuinea-BissauEquatorial GuineaGreeceGreenlandGuatemalaGuyanaHondurasCroatiaHaitiHungaryIndonesiaIndia: 3IrelandIslamic Republic of IranIraqIcelandIsraelItalyJamaicaJordanJapan: 3KazakhstanKenyaKyrgyzstanCambodiaRepublic of South KoreaKuwaitLao People's Democratic RepublicLebanonLiberiaLibyaSri LankaLesothoLithuaniaLuxembourgLatviaMoroccoRepublic of MoldovaMadagascarMexicoMacedoniaMaliMyanmarMontenegroMongoliaMozambiqueMauritaniaMalawiMalaysiaNamibiaNigerNigeriaNicaraguaNetherlandsNorwayNepalNew ZealandOmanPakistanPanamaPeruPhilippinesPapua New GuineaPolandDemocratic People's Republic of KoreaPortugalParaguayState of PalestineQatarRomaniaRussian FederationRwandaWestern SaharaSaudi ArabiaSudanSouth SudanSenegalSierra LeoneEl SalvadorSerbiaSurinameSlovakiaSloveniaSwedenEswatiniSyrian Arab RepublicChadTogoThailandTajikistanTurkmenistanTimor-LesteTunisiaTurkeyTaiwanUnited Republic of TanzaniaUgandaUkraineUruguayUnited States of AmericaUzbekistanVenezuelaViet NamVanuatuYemenSouth AfricaZambiaZimbabweSomaliaFrench GuianaFranceSpainArubaAnguillaAntigua and BarbudaBahamasBermudaBarbadosComorosCabo VerdeCayman IslandsDominicaFalkland IslandsFaroe IslandsGrenadaHong KongSaint Kitts and NevisSaint LuciaLiechtensteinMaldivesMaltaMontserratMauritiusNew CaledoniaNauruPitcairnPuerto RicoFrench PolynesiaSingaporeSolomon IslandsSao Tome and PrincipeSint MaartenSeychellesTurks and Caicos IslandsTongaTrinidad and TobagoSaint Vincent and the GrenadinesVirgin IslandsVirgin IslandsCyprusRéunionMayotteMartiniqueGuadeloupeCuraçaoIc

Cellbricks GmbH was recently referenced in connection with the following countries in press releases, job postings, register filings, and associated social media channels. Canada, India and Japan were mentioned in this context with the highest frequency.

memoryTechnology Profileinsert_link

Artificial IntelligenceKünstliche Intelligenz
AutomationAutomation Technology
Corporate ITCloud
Virtual Reality
Customer Experience ManagementUser Experience
Devices3D Systems
Stratasys
Internet of ThingsIndustrie 4.0
Software DevelopmentPrototyping

The following software solutions, technologies and concepts are often referenced in job postings and press releases of Cellbricks GmbH. Most frequently recognized were Stratasys, Künstliche Intelligenz and Cloud.

codeIntegration via APIinsert_link

content_copy
  1. curl \
  2. --silent \
  3. --request GET \
  4. --header "Content-Type: application/json" \
  5. --url "https://implisen.se/DET1KJLGFI79" | jq '.'
play_arrow
  •  
content_copy
  1. require 'json'
  2. require 'net/http'
  3. uri = URI('https://implisen.se/DET1KJLGFI79')
  4. response = Net::HTTP.get(uri)
  5. puts JSON.parse(response)
play_arrowcontent_copy
  •  
content_copy
  1. const https = require('https');
  2. https.get('https://implisen.se/DET1KJLGFI79', (response) => {
  3. let data = '';
  4. response.on('data', (chunk) => {
  5. data += chunk;
  6. });
  7. response.on('end', () => {
  8. console.log(JSON.parse(data));
  9. });
  10. });
play_arrowcontent_copy
  •  
content_copy
  1. import urllib.request
  2. import json
  3. from pprint import pprint
  4. response = urllib.request.urlopen('https://implisen.se/DET1KJLGFI79').read()
  5. pprint(json.loads(response))
play_arrowcontent_copy
  •  
content_copy
  1. package main
  2. import( "net/http"
  3. "io/ioutil"
  4. "bytes"
  5. "encoding/json"
  6. "fmt"
  7. func main() {
  8. response, _ := http.Get("https://implisen.se/DET1KJLGFI79")
  9. defer response.Body.Close()
  10. payload, _ := ioutil.ReadAll(response.Body)
  11. var out bytes.Buffer
  12. json.Indent(&out, payload, "", " ")
  13. fmt.Println(string(out.Bytes()))
play_arrowcontent_copy
  •  

With the Implisense API you can enrich your CRM or ERP system with public data on over 2 million companies. Via the RapidAPI marketplace you can directly access our API. For further information, please refer to our internal page on the Implisense API.

Register your Implisense account for free

Register quickly and easily for a free Implisense account. Registered users have access to advanced analyses and more key figures on company profiles, receive more extensive search results and can also create and manage their own favorites.

  • content_copy
    Richer Company Profiles
  • search
    Expanded Search Results
  • star_border
    Personal Favourites and Notes
The information presented on implisense.com comes from public sources and is verified and aggregated automatically. Implisense cannot guarantee the timeliness, completeness, quality, reliability or accuracy of the data. For questions or suggestions, please use the contact form.

This website uses cookies to provide this service and improve the user experience. Please select the cookies you wish to accept. You can find further information in our data protection declaration.

Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Matomo and Google Analytics, which set cookies for user identification. While Google Analytics is a service offered by a third party provider, Matomo is operated by Implisense GmbH, all collected data is not made available to third parties.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.
Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Matomo and Google Analytics, which set cookies for user identification. While Google Analytics is a service offered by a third party provider, Matomo is operated by Implisense GmbH, all collected data is not made available to third parties.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.

Save selectionSelect all